MedPath
NMPA Approval

Paliperidone Palmitate Injection

国药准字H20243894

June 4, 2024

Drug Information

棕榈酸帕利哌酮注射液

注射剂

0.25ml:25mg (按C₂₃H₂₇FN₄O₃计)

化学药品

June 4, 2024

Company Information

Applicant Company

石家庄高新区裕华东路455号润江总部国际大厦5层

Manufacturing Company

山东省烟台市高新区创业路15号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

棕榈酸帕利哌酮注射液 - NMPA 批准文号 | MedPath